IP Verse

Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved - EP2560662

The patent EP2560662 was granted to Alfasigma on Jun 7, 2017. The application was originally filed on Apr 20, 2011 under application number EP11723652A. The patent is currently recorded with a legal status of "Revoked".

EP2560662

ALFASIGMA
Application Number
EP11723652A
Filing Date
Apr 20, 2011
Status
Revoked
Mar 6, 2020
Grant Date
Jun 7, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOTTI & FERRARIMar 7, 2018FERRECCIO -
GENERICS UKMar 7, 2018FRKELLY -

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP1292315
DESCRIPTIONUS3936351
DESCRIPTIONUS4705798
DESCRIPTIONUS5455258
DESCRIPTIONWO9005719
DESCRIPTIONWO9402447
DESCRIPTIONWO9720824
EXAMINATIONEP0950413
EXAMINATIONWO2009121959
OPPOSITIONWO2009121959
OPPOSITIONWO2011051726

Non-Patent Literature (NPL) Citations (50) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BERGAM J. ET AL., ANN. VASC. SURG., (2007), vol. 21, pages 260 - 266-
DESCRIPTION- CAENAZZO I. ET AL., NEPHROL. DIAL. TRANSPLANT, (2001), vol. 16, pages 1769 - 75-
DESCRIPTION- CELL BIOL. INT., (2003), vol. 27, pages 779 - 84-
DESCRIPTION- CERIELLO A. ET AL., DIAB. NUTR. METAB., (1993), vol. 6, pages 1 - 4-
DESCRIPTION- DEROSA G. ET AL., DIABETES METAB., (2007), vol. 33, pages 129 - 134-
DESCRIPTION- GALIS Z.S. ET AL., CIRC. RES., (2002), vol. 90, pages 251 - 262-
DESCRIPTION- HARENBERG J., MED. RES. REV., (1998), vol. 18, pages 1 - 20-
DESCRIPTION- HIDALGO M. ET AL., J. NATL. CANCER INST., (2001), vol. 93, pages 178 - 193-
DESCRIPTION- KADOGLOU N.P. ET AL., ANGIOLOGY, (2005), vol. 56, pages 173 - 189-
DESCRIPTION- LAEMMLI U.K, NATURE, (1970), vol. 227, pages 680 - 685-
DESCRIPTION- MANNELLO F. ET AL., ARTERIOSCLER. THROMB. VASC. BIOL., (2008), vol. 28, pages 611 - 614-
DESCRIPTION- MANNELLO F. ET AL., CLIN. BIOCHEM., (2008), vol. 41, pages 1466 - 73-
DESCRIPTION- MANNELLO F. ET AL., CLIN. CHEM., (2003), vol. 49, pages 339 - 34-
DESCRIPTION- MANNELLO F. ET AL., CURR. CANCER DRUG TARGETS, (2005), vol. 5, pages 285 - 298-
DESCRIPTION- NELSON A. ET AL., J. CLIN. ONCOL., (2000), vol. 18, pages 1135 - 1149-
DESCRIPTION- OFOSU F.A., SEMIN. THROMB. HEMOST., (1998), vol. 24, pages 127 - 38-
DESCRIPTION- RAFFETTO JD. ET AL., BIOCHEM. PHARMACOL., (2008), vol. 75, pages 346 - 359-
DESCRIPTION- RAFFETTO JD. ET AL., THROMB. RES., (2009), vol. 123, pages S66 - S71-
DESCRIPTION- RAHKO E. ET AL., TUMOR BIOL., (2009), vol. 30, no. 5-6, pages 574 - 64-
DESCRIPTION- RAMNATH N. ET AL., CURR. ONCOL. REP., (2004), vol. 6, pages 96 - 102-
DESCRIPTION- TAMARIN R., MEDICAL PRAXIS, (1997), vol. 8, page 1-
DESCRIPTION- TAYEBJEE M.H. ET AL., DIABETES CARE, (2004), vol. 27, pages 2049 - 2051-
DESCRIPTION- TU G. ET AL., CURR. MED. CHEM., (2008), vol. 15, pages 1388 - 1395-
DESCRIPTION- VIHINEN ET AL., INT. J. CANCER, (2002), vol. 99, pages 157 - 166-
EXAMINATION- MANNELLO FERDINANDO ET AL, "Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research", AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, (20111101), vol. 3, no. 2, pages 149 - 158, XP008163755-
EXAMINATION- MANNELLO F ET AL, "Matrix metalloproteinase inhibitors as anticancer therapeutics", CURRENT CANCER DRUG TARGETS, BENTHAM SCIENCE PUBLISHERS, HILVERSUM, NL, (20050601), vol. 5, no. 4, ISSN 1568-0096, pages 285 - 298, XP008129213-
EXAMINATION- M. R. MILANI ET AL., "Pharmacokinetics of sulodexide evaluated from 131I-labeled fast moving heparin after single intravenous and oral administration of different doses in Man", BRITISH JOURNAL OF CLINICAL RESEARCH, (1992), vol. 3, pages 161 - 178-
EXAMINATION- P.A. Van Zwieten, Handbook of hypertension Volume 3. Pharmacology of antihypertensive drugs, (1984), pages 307 - 330-
EXAMINATION- RAFFETTO JD. ET AL., BIOCHEM. PHARMACOL., (2008), vol. 75, pages 346 - 359-
EXAMINATION- SAVIANO M ET AL, "Double-blind, double-dummy, randomized, multi-centre clinical assessment of the efficacy, tolerability and dose-effect relationship of sulodexide in chronic venous insufficiency", CURRENT MEDICAL RESEARCH AND OPINION 1993 GB, (1993), vol. 13, no. 2, ISSN 0300-7995, pages 96 - 108-
INTERNATIONAL-SEARCH-REPORT- COCCHERI SERGIO ET AL, "Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers", THROMBOSIS AND HAEMOSTASIS, SCHATTAUER GMBH, DE; US, (20020501), vol. 87, no. 6, ISSN 0340-6245, pages 947 - 952, XP008129237 [X] 1,4-9 * page 952, column 1, paragraph 2 *-
INTERNATIONAL-SEARCH-REPORT- CONDORELLI M ET AL, "IPO-V2: A PROSPECTIVE, MULTICENTER, RANDOMIZED, COMPARATIVE CLINICAL INVESTIGATION OF THE EFFECTS OF SULODEXIDE IN PREVENTING CARDIOVASCULAR ACCIDENTS IN THE FIRST YEAR AFTER ACUTE MYOCARDINAL INFARCTION", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER, NEW YORK, NY, US, (19940101), vol. 23, no. 1, ISSN 0735-1097, pages 27 - 34, XP000882515 [X] 1,4-9 * page 32, column 2, paragraph 5 - page 33, column 1, paragraph 1 *-
INTERNATIONAL-SEARCH-REPORT- GADDI ET AL, "Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease", JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, CAMBRIDGE MEDICAL PUBLICATIONS LTD, GB, (19960901), vol. 24, no. 5, ISSN 0300-0605, pages 389 - 406, XP002117945 [X] 1,4-9 * page 390, column 2, paragraph 1 *-
INTERNATIONAL-SEARCH-REPORT- OFOSU F A, "Pharmacological actions of sulodexide", SEMINARS IN THROMBOSIS AND HEMOSTASIS, STUTTGART, DE, (19980101), vol. 24, no. 2, ISSN 0094-6176, pages 127 - 138, XP008129231 [X] 1,4-9 * abstract *-
INTERNATIONAL-SEARCH-REPORT- COCCHERI S ET AL, "Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study", EUROPEAN HEART JOURNAL, (200207), vol. 23, no. 13, ISSN 0195-668X, pages 1057 - 1065, XP002610488 [X] 1,4-9 * page 1063, column 1, paragraph 5 - page 1064, column 1, paragraph 4 *
INTERNATIONAL-SEARCH-REPORT- VERSTRAETE M ET AL, "NOVEL ANTITHROMBOTIC DRUGS IN DEVELOPMENT", DRUGS, ADIS INTERNATIONAL LTD, NZ, (19950601), vol. 49, no. 6, doi:DOI:10.2165/00003495-199549060-00002, ISSN 0012-6667, pages 856 - 884, XP001063907 [X] 1,4-9 * page 867, column 1, paragraph 4 - column 2, paragraph 4 *
OPPOSITION- BERGAM J. et al., "Molecular Mechanisms in Chronic Venous Insufficiency", Ann. Vasc. Surg., (20070000), vol. 21, pages 260 - 266, XP022063997-
OPPOSITION- COCCHERI SERGIO et al., "Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers", THROMBOSIS AND HAEMOSTASIS, (20020501), vol. 87, no. 6, pages 947 - 952, XP008129237-
OPPOSITION- CONDORELLI M et al., "IPO-V2: A PROSPECTIVE, MULTICENTER, RANDOMIZED, COMPARATIVE CLINICAL INVESTIGATION OF THE EFFECTS OF SULODEXIDE IN PREVENTING CARDIOVASCULAR ACCIDENTS IN THE FIRST YEAR AFTER ACUTE MYOCARDINAL INFARCTION", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, (19940000), vol. 23, no. 1, pages 27 - 34, XP000882515-
OPPOSITION- Elna M. Masuda et al, "Practical Application of the CEAP Classification", Chronic Venous insufficiency, (20000000), pages 41 - 49, XP055472129-
OPPOSITION- MANNELLO FERDINANDO et al., "Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research", AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, (20111101), vol. 3, no. 2, pages 149 - 158, XP008163755-
OPPOSITION- MANNELLO F et al., "Matrix metalloproteinase inhibitors as anticancer therapeutics", CURRENT CANCER DRUG TARGETS, HILVERSUM, NL, (20050601), vol. 5, no. 4, pages 285 - 298, XP008129213-
OPPOSITION- M. BRUNETTI et al., "SULODEXIDE NEL TRATTAMENTO DELLE TROMBOSI VENOSE. VALUTAZIONI CLINICHE A CONFRONTO", IL CONTINUUM DEL PAZIENTE VASCOLARE, URL: http://www.omikronitalia.it/images/pubblicazioni/continuum_sulodexide_n1_2011_a.pdf-
OPPOSITION- M. R. MILANI et al., "Pharmacokinetics of sulodexide evaluated from 131I-labelled fast moving heparin after single intravenous and oral administration of different doses in Man", BRITISH JOURNAL OF CLINICAL RESEARCH, (19920000), vol. 3, pages 161 - 178, XP055472834-
OPPOSITION- OFOSU F A, "Pharmacological actions of sulodexide", SEMINARS IN THROMBOSIS AND HEMOSTASIS, (19980101), vol. 24, no. 2, pages 127 - 138, XP008129231-
OPPOSITION- P.A. VAN ZWIETEN, "10. Vasodilator drugs with direct action on smooth muscle", Handbook of hypertension, (19840000), vol. 3, pages 307 - 330, XP055472802-
OPPOSITION- RAFFETTO et al., "Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K^+ channels: Relevance to varicose vein formation", J Vasc Surg, (20070000), vol. 45, no. 2, pages 373 - 80, XP005859831
OPPOSITION- COCCHERI S et al., "Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study", EUROPEAN HEART JOURNAL, (20020701), vol. 23, no. 13, pages 1057 - 1065, XP008129487
OPPOSITION- SAVIANO et al., "Double-blind, double-dummy, randomized, multi-centre clinical assessment of the efficacy, tolerability and dose-effect relationship of sulodexide in chronic venous insufficiency", Current Medical Research and Opinion, (19930000), vol. 13, pages 96 - 108, XP008178770
OPPOSITION- SAVIANO M et al., "Double-blind, double-dummy, randomized, multi-centre clinical assessment of the efficacy, tolerability and dose-effect relationship of sulodexide in chronic venous insufficiency", CURRENT MEDICAL RESEARCH AND OPINION 1993 GB, (19930000), vol. 13, no. 2, pages 96 - 108, XP008178770

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents